Patents by Inventor Chrishan S. Samuel

Chrishan S. Samuel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of modulating apoptosis by administration of relaxin agonists or antagonists
    Patent number: 9534034
    Abstract: The present invention relates to the discovery that relaxin is associated with the development or maturation of body tissues. Knockouts of the gene encoding relaxin result in various abnormalities in the development of various tissues. The present invention provides methods of modulating apoptosis by administering a relaxin agonist or antagonist to a subject.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: January 3, 2017
    Assignee: Molecular Medicine Research Institute
    Inventors: Edward P. Amento, Chrishan S. Samuel
  • METHODS OF MODULATING APOPTOSIS BY ADMINISTRATION OF RELAXIN AGONISTS OR ANTAGONISTS
    Publication number: 20120238499
    Abstract: The present invention relates to the discovery that relaxin is associated with the development or maturation of body tissues. Knockouts of the gene encoding relaxin result in various abnormalities in the development of various tissues. The present invention provides methods of modulating apoptosis by administering a relaxin agonist or antagonist to a subject.
    Type: Application
    Filed: February 17, 2012
    Publication date: September 20, 2012
    Applicant: MOLECULAR MEDICINE RESEARCH INSTITUTE
    Inventors: Edward P. Amento, Chrishan S. Samuel
  • METHODS OF MODULATING APOPTOSIS BY ADMINISTRATION OF RELAXIN AGONISTS OR ANTAGONISTS
    Publication number: 20110059108
    Abstract: The present invention relates to the discovery that relaxin is associated with the development or maturation of body tissues. Knockouts of the gene encoding relaxin result in various abnormalities in the development of various tissues. The present invention provides methods of modulating apoptosis by administering a relaxin agonist or antagonist to a subject.
    Type: Application
    Filed: November 12, 2010
    Publication date: March 10, 2011
    Applicant: MOLECULAR MEDICINE RESEARCH INSTITUTE
    Inventors: Edward P. Amento, Chrishan S. Samuel
  • Methods of modulating apoptosis by administration of relaxin agonists or antagonists
    Patent number: 7833526
    Abstract: The present invention relates to the discovery that relaxin is associated with the development or maturation of body tissues. Knockouts of the gene encoding relaxin result in various abnormalities in the development of various tissues. The present invention provides methods of modulating apoptosis by administering a relaxin agonist or antagonist to a subject.
    Type: Grant
    Filed: July 23, 2007
    Date of Patent: November 16, 2010
    Assignee: Molecular Medicine Research Institute
    Inventors: Edward P. Amento, Chrishan S. Samuel